Key result
Chronic amiodarone preferentially suppressed arrhythmogenic substrates and triggers in canine pulmonary vein sleeves, increasing the basic cycle length for 1:1 activation failure from 124 to 420 ms.
Why the study?
Does chronic amiodarone alter the electrophysiological characteristics and suppress triggered activity in canine pulmonary vein sleeve preparations?
Does chronic amiodarone alter the electrophysiological characteristics and suppress triggered activity in canine pulmonary vein sleeve preparations?
Chronic amiodarone preferentially suppresses arrhythmogenic substrates and triggers in canine pulmonary vein sleeves, highlighting a potential mechanism for its efficacy in atrial fibrillation.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for amiodarone's PV effects in AF models; leaves open translation to human therapy.
OBJECTIVES: To examine the effects of chronic amiodarone on the electrophysiology of canine pulmonary vein (PV) sleeve preparations and left ventricular wedge preparation. BACKGROUND: Amiodarone is commonly used for the treatment of ventricular and supraventricular arrhythmias. Ectopic activity arising from the PV plays a prominent role in the development of atrial fibrillation (AF). METHODS: Standard microelectrode techniques were used to evaluate the electrophysiological characteristics of superfused PV sleeve (left superior or inferior) and arterially perfused left ventricular (LV) wedge preparations isolated from untreated and chronic amiodarone-treated dogs (amiodarone, 40 mg/kg daily for 6 weeks). RESULTS: In PV sleeves, chronic amiodarone (n = 6) induced a significant increase in action potential duration at 90% repolarization (APD90) and a significant use-dependent reduction in Vmax leading to 1:1 activation failure at long cycle lengths (basic cycle length of 124 +/- 15 ms in control vs 420 +/- 320 ms after chronic amiodarone [P < 0.01]). Diastolic threshold of excitation increased from 0.3 +/- 0.2 to 1.8 +/- 0.7 mA (P < 0.01). Delayed and late phase 3 early afterdepolarizations and triggered activity could be induced in PV sleeve preparations using acetylcholine (ACh, 1 microM), high calcium ([Ca2+]o = 5.4 mM), isoproterenol (Iso, 1 microM), or their combination in 6 of 6 untreated PV sleeves, but in only 1 of 5 chronic amiodarone-treated PV sleeve preparations. Vmax, conduction velocity, and 1:1 activation failure were much more affected in PV sleeves versus LV wedge preparations isolated from amiodarone-treated animals. CONCLUSIONS: The results point to potent effects of chronic amiodarone to preferentially suppress arrhythmogenic substrates and triggers arising from the PV sleeves of the dog.
No takes yet. Share an insight, caveat, or question.
Sicouri et al. (2009) studied Arrhythmia. Amiodarone vs. Untreated was evaluated on Basic cycle length leading to 1:1 activation failure (ms) (p=<0.01). Chronic amiodarone preferentially suppressed arrhythmogenic substrates and triggers in canine pulmonary vein sleeves, increasing the basic cycle length for 1:1 activation failure from 124 to 420 ms.
Synapse has enriched 10 related papers. Consider them for comparative context: